Skip to main content
. 2018 Sep 4;7(4):407–419. doi: 10.1007/s40121-018-0210-5

Table 2.

Current EASL Guidelines (2017) [76]

Phase sAg eAg HBV DNA ALT Liver disease
eAg-positive chronic infection High Positive > 107 IU/ml Normal None/minimal
eAg-positive chronic hepatitis High/intermediate Positive 104–107 IU/ml Elevated Moderate/severe
eAg-negative chronic infection Low Negative < 2000 IU/ml Normal None
eAg-negative chronic infection Intermediate Negative > 2000 IU/ml Elevated Moderate/severe